GALT
insider transactionsGALECTIN THERAPEUTICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-568
0 buy · 568 sell
Net value · 90d
-$1.8K
$0 in · $1.8K out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 568 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Medical Officer · 10b5-1
$0
568 sh
Own +1%
-
Sell·S
Chief Medical Officer · 10b5-1
$1.8K
568 sh · $3.10
Own -100%
-
Exercise·M
Chief Medical Officer · 10b5-1
$699
568 sh · $1.23
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 26, 2026 | Khurram Jamil 10b5-1 | Exercise M | 568 | $0 |
| May 26, 2026 | Khurram Jamil 10b5-1 | Sell S | 568 | $1.8K |
| May 26, 2026 | Khurram Jamil 10b5-1 | Exercise M | 568 | $699 |
About GALT insider trading
This page tracks insider transactions for GALECTIN THERAPEUTICS INC (GALT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.